{"id":1084,"date":"2026-07-06T06:02:08","date_gmt":"2026-07-06T06:02:08","guid":{"rendered":"https:\/\/isbm-blow-molding.com\/?p=1084"},"modified":"2026-07-06T06:02:08","modified_gmt":"2026-07-06T06:02:08","slug":"crc-pharmaceutical-injection-blow-molding","status":"publish","type":"post","link":"https:\/\/isbm-blow-molding.com\/et\/crc-pharmaceutical-injection-blow-molding\/","title":{"rendered":"CRC Pharmaceutical IBM: lapsekindlate pakendite juhend"},"content":{"rendered":"<div style=\"margin: 0; padding: 0; font-family: 'Helvetica Neue',Helvetica,Arial,sans-serif; color: #1a2332; line-height: 1.78; background: #f0f3f7; overflow-x: hidden;\">\n<p><!-- \u2550\u2550 HERO \u2550\u2550 --><\/p>\n<header style=\"position: relative; min-height: min(600px,88vh); display: flex; align-items: flex-end; width: 100%; background: #0c0e1a; background-image: linear-gradient(155deg,rgba(8,10,22,0.97) 0%,rgba(16,20,48,0.93) 52%,rgba(30,48,110,0.60) 100%),url('https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Pharmaceutical-Bottles.webp'); background-size: cover; background-position: center 35%;\">\n<div style=\"position: absolute; top: 0; left: 0; right: 0; height: 5px; background: linear-gradient(90deg,#d97706,#f59e0b,#d97706);\"><\/div>\n<div style=\"position: absolute; bottom: -1px; left: 0; right: 0; height: 56px; background: #f0f3f7; clip-path: polygon(0 100%,100% 100%,100% 0);\"><\/div>\n<div style=\"position: relative; z-index: 2; width: 100%; padding: clamp(48px,7vw,96px) clamp(20px,5vw,60px) clamp(52px,6vw,84px); box-sizing: border-box;\">\n<div style=\"display: inline-flex; align-items: center; gap: 8px; margin-bottom: 20px;\">\n<div style=\"width: 28px; height: 3px; background: #d97706;\"><\/div>\n<p><span style=\"font-size: 10px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #f59e0b;\">CRC PHARMACEUTICAL IBM \u00b7 KS M ISO 8317 \u00b7 Korea KFDA \u00b7 Korea EVER-POWER<\/span><\/p>\n<div style=\"width: 28px; height: 3px; background: #d97706;\"><\/div>\n<\/div>\n<h1 style=\"font-size: clamp(26px,4.6vw,46px); font-weight: 900; color: #fff; line-height: 1.1; margin: 0 0 20px; letter-spacing: -0.8px; max-width: 720px;\">CRC Pharmaceutical IBM:<br \/>\n<span style=\"color: #f59e0b;\">Lapsekindel<\/span> Konteinerite juhend<\/h1>\n<p style=\"font-size: clamp(14px,1.9vw,17px); color: #94a3b8; line-height: 1.7; margin: 0 0 30px; max-width: 600px;\">Korea lapsekindla sulguriga (CRC) ravimimahutid on rakendus, kus IBM-i kaela v\u00e4lisl\u00e4bim\u00f5\u00f5du t\u00e4psus \u00b10,05 mm ei ole pelgalt eelis EBM-i ees \u2013 see on Korea KS M ISO 8317 vastavuse eeltingimus. See juhend h\u00f5lmab CRC kinnitusmehhanismi f\u00fc\u00fcsikat, IBM-i kaela geomeetria spetsifikatsioone, Korea ISO 8317 katsen\u00f5udeid, HDPE klassi valikut ja ZQ-seeria masina valikut Korea CRC ravimimahutite tootmiseks.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 6px;\"><span style=\"background: rgba(217,119,6,0.15); border: 1px solid rgba(217,119,6,0.45); color: #fbbf24; font-size: 11px; font-weight: bold; padding: 4px 12px; border-radius: 2px; letter-spacing: 1px; text-transform: uppercase;\">KS M ISO 8317 vastavus<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.06); border: 1px solid rgba(255,255,255,0.15); color: #94a3b8; font-size: 11px; font-weight: bold; padding: 4px 12px; border-radius: 2px; letter-spacing: 1px; text-transform: uppercase;\">CRC-graanuli v\u00e4lisdiameeter \u00b10,05 mm<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.06); border: 1px solid rgba(255,255,255,0.15); color: #94a3b8; font-size: 11px; font-weight: bold; padding: 4px 12px; border-radius: 2px; letter-spacing: 1px; text-transform: uppercase;\">L\u00fckka-ja-keera mehhanism<\/span><\/div>\n<p style=\"font-size: 11px; color: #475569; margin: 22px 0 0; letter-spacing: 1px;\">KOREA IGAVENE V\u00d5IM \u00b7 ANSAN-SI, GYEONGGI-DO \u00b7 JUULI 2026<\/p>\n<\/div>\n<\/header>\n<p>&nbsp;<\/p>\n<p><!-- SPEC PANEL --><\/p>\n<div style=\"background: #0f1e35; border: 1px solid #1e3a5f; border-left: 4px solid #d97706; border-radius: 4px; padding: 24px 28px; margin: 52px 0 0;\">\n<div style=\"display: flex; align-items: center; gap: 10px; margin-bottom: 18px;\">\n<div style=\"width: 16px; height: 16px; border: 2px solid #d97706; border-radius: 50%; display: flex; align-items: center; justify-content: center; flex-shrink: 0;\">\n<div style=\"width: 6px; height: 6px; background: #d97706; border-radius: 50%;\"><\/div>\n<\/div>\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0;\">S\u00dcSTEEMI VIIDE \u00b7 KOREA CRC FARMATSEUTIKA IBM-I PARAMEETRID<\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,170px),1fr)); gap: 1px; background: #1e3a5f;\">\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">CRC RANDI V\u00c4LISM\u00d5\u00d5TMETA TOLERANTS<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">IBM-i survevalu \u2014 Korea ISO 8317 aken \u00b10,06 mm<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">KS M ISO 8317 T\u00c4ISKASVANUTELE<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u2265 85%<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">Avamiskiirus 5 minuti jooksul \u2014 200 t\u00e4iskasvanud katsealust<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">KS M ISO 8317 LAPSE<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u2264 20%<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">Avamiskiirus 10 minuti jooksul \u2014 200 last (42\u201351 kuud)<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">HDPE RANDI J\u00c4IKUS<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">MI 0,5\u20130,8<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">g\/10 min \u00b7 tihedus 0,955\u20130,965 \u2014 rant peab vastu CRC allasurumise deformatsioonile<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><!-- TOC --><\/p>\n<nav style=\"margin: 28px 0 0; background: #fff; border: 1px solid #cbd5e0; border-radius: 4px; padding: 22px 26px; position: relative; overflow: hidden;\">\n<div style=\"position: absolute; inset: 0; background-image: linear-gradient(rgba(30,58,95,0.03) 1px,transparent 1px),linear-gradient(90deg,rgba(30,58,95,0.03) 1px,transparent 1px); background-size: 24px 24px; pointer-events: none;\"><\/div>\n<div style=\"position: relative;\">\n<div style=\"display: flex; align-items: center; gap: 8px; margin-bottom: 14px;\">\n<div style=\"width: 3px; height: 14px; background: #d97706; border-radius: 2px;\"><\/div>\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 2.5px; text-transform: uppercase; color: #1e3a5f; margin: 0;\">DOKUMENTIDE INDEKS<\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,270px),1fr)); gap: 2px 24px;\"><a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s1\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">01<\/span>Korea CRC ravimiturg ja IBM<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s2\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">02<\/span>CRC haakemehhanism ja IBM Neck Precision<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s3\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">03<\/span>Korea KS M ISO 8317 testimisn\u00f5uded<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s4\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">04<\/span>HDPE klass ja helmeste geomeetria CRC IBM jaoks<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s5\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">05<\/span>IBM-i t\u00f6\u00f6tlemisparameetrid CRC-konteinerite jaoks<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s6\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">06<\/span>CRC formaadivahemik ja kaela viimistluse valik<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s7\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">07<\/span>CRC + induktsioontihendi kombineeritud formaat<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s8\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">08<\/span>ZQ seeria valik Korea CRC IBM-ile<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline;\" href=\"#faq\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">KKK<\/span>Insenerik\u00fcsimused<\/a><\/div>\n<\/div>\n<\/nav>\n<p><!-- \u2550\u2550 S1 \u2550\u2550 --><\/p>\n<div style=\"padding: 0px 2%;\">\n<section id=\"s1\" style=\"margin: 64px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 01<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">Korea CRC farmaatsiakonteinerite turg ja IBM<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Lapsekindla sulguriga (CRC) ravimipakendid on Koreas kohustuslikud teatud ja pidevalt laieneva farmaatsiatoodete kategooriate puhul \u2013 Korea tervisekindlustuse l\u00e4bivaatamise ja hindamise teenistus (HIRA) n\u00f5uab CRC-pakendit k\u00f5igi Korea retseptiravimite puhul, mis sisaldavad toksilisi toimeaineid \u00fcle kindlaksm\u00e4\u00e4ratud annusk\u00fcnniste, k\u00f5igi Korea retseptiravimite puhul, mida jaotatakse alla kuueaastaste lastega leibkondadele, ja k\u00f5igi Korea k\u00e4sim\u00fc\u00fcgiravimite puhul tablettide ja vedelate valuvaigistite puhul, mis \u00fcletavad standardset \u00fchikdoosi pakendit. Korea toidu- ja ravimiohutusministeeriumi (MFDS\/KFDA) CRC n\u00f5uete j\u00f5ustamine on alates 2020. aastast j\u00e4rk-j\u00e4rgult karmistunud, laiendades CRC esmast pakendit n\u00f5udvate Korea farmaatsiatoodete loetelu algsest kitsast ravimikategooriate loetelust kaugemale.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\"><a href=\"https:\/\/isbm-blow-molding.com\/et\/product-category\/4-station-isbm-machine\/\">IBM<\/a> on Korea farmaatsiatoodete CRC-mahutite eksklusiivne puhumisvormimisprotsess, kuna l\u00fckatava ja p\u00f6\u00f6ratava CRC-mehhanismi haakumistolerantsi aken (\u00b10,06 mm kaela haakumistelendi v\u00e4lisl\u00e4bim\u00f5\u00f5dul) j\u00e4\u00e4b IBM-i loomuliku \u00b10,05 mm kaelat\u00e4psuse piiridesse, kuid \u00fcletab EBM-i kaelatolerantsi \u00b10,15\u20130,25 mm 3\u20135 korda. \u00dckski EBM-mahutitele rakendatav sekundaarne kaelat\u00f6\u00f6tlus ei suuda usaldusv\u00e4\u00e4rselt saavutada \u00b10,06 mm CRC haakumistelendi v\u00e4lisl\u00e4bim\u00f5\u00f5tu 2\u20134 \u00f5\u00f5nsuse ulatuses Korea farmaatsiatoodete villimisliinide jaoks vajalikul tootmiskiirusel \u2013 kaelat\u00f6\u00f6tluse h\u00f5\u00f5ritsemisoperatsiooni enda m\u00f5\u00f5tmete varieeruvus (\u00b10,08\u20130,12 mm h\u00f5\u00f5ritsemistelternatsioon) \u00fcletab CRC haakumistelendi akent. IBM k\u00f5rvaldab selle protsessiahela, tootes survevaluvormi kaelasisus \u00b10,05 mm haakumistelendi peamise protsessiv\u00f5imalusena, mitte sekundaarse viimistluse tulemusena.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Laiem farmaatsiatoodete IBM-i juhend h\u00f5lmab p\u00f5hjalikult Korea farmaatsiatoodete esmaste konteinerite formaate. See juhend keskendub spetsiaalselt CRC konteinerite IBM-ile \u2013 kinnitusmehhanismi f\u00fc\u00fcsikalistele omadustele, kaela geomeetria spetsifikatsioonidele, Korea standardi ISO 8317 vastavusele, HDPE klassi valikule ja tootmis\u00f6konoomikale, mis on CRC farmaatsiatoodete IBM-i formaadile ainuomased.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S2 \u2550\u2550 --><\/p>\n<section id=\"s2\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 02<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">CRC haakemehhanism ja IBM Neck Precision<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"IBM CRC kaela t\u00e4ppis- \u2014 s\u00fcdamiku varda mehhanism Korea EverPower\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-Internal-structure.webp\" alt=\"Korea Ever-Power ZQ seeria IBM-i masina sisemine struktuur, mis n\u00e4itab s\u00fcdamiku varda mehhanismi, mis hoiab CRC haardumisr\u00f5nga geomeetriat sissepritse- ja puhumisfaasi ajal \u2013 tekitades \u00b10,05 mm r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du k\u00f5igis \u00f5\u00f5nsustes Korea KS M ISO 8317 l\u00fckatava ja p\u00f6\u00f6ratava CRC ravimimahuti tootmiseks.\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">IBM-i s\u00fcdamikvarda mehhanism on CRC kaela t\u00e4psuse f\u00fc\u00fcsiline alus. S\u00fcdamikvarras l\u00e4bib CRC haardumisprofiili tsooni 1. jaamas (sissepritse) ja 2. jaamas (puhumine), hoides profiili geomeetriat t\u00e4pselt sellisena, nagu survevaluvormi kaela siset\u00fckk on m\u00e4\u00e4ranud m\u00f5lema protsessifaasi v\u00e4ltel. Puhumis\u00f5hu r\u00f5hk 2. jaamas ei puutu kunagi profiiliga kokku \u2013 see toimib ainult tooriku kehale, mis asub profiili tsooni all. See profiili geomeetria struktuurne lahutamine puhumisr\u00f5hust on p\u00f5hjus, miks IBM saavutab CRC profiili v\u00e4lisl\u00e4bim\u00f5\u00f5du \u00b10,05 mm, samas kui EBM, kus puhumisr\u00f5hk moodustab kogu anuma, sealhulgas kaela, ei saa saavutada \u00b10,06 mm ilma kaela sekundaarse viimistluseta.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">L\u00fckka-ja-keeratav CRC kork toimib mehaanilise interferentsi abil HDPE IBM-i pudelikaelal oleva \u00fcmberm\u00f5\u00f5dulise kinnitusr\u00f5nga ja CRC korgi \u00e4\u00e4rise sisek\u00fcljel asuva sobiva kinnitusmehhanismi vahel. Haakemehhanismi f\u00fc\u00fcsika m\u00f5istmine on IBM-i kaela siset\u00fcki geomeetria \u00f5igeks m\u00e4\u00e4ramiseks oluline.<\/p>\n<p><!-- CRC mechanism diagram panel --><\/p>\n<div style=\"background: #0f1e35; border-radius: 4px; overflow: hidden; margin: 0 0 22px; border-top: 3px solid #d97706;\">\n<div style=\"padding: 14px 20px; border-bottom: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0;\">L\u00dcKKA-JA-P\u00d6\u00d6RAV KETTIGA KEHTESTAMISMEHAANIKA JA IBM-I KAELATOLERANTSI KETT<\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(3,1fr); gap: 0;\">\n<div style=\"padding: 16px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 10px; font-weight: bold; color: #f59e0b; margin: 0 0 10px; letter-spacing: 1px; text-transform: uppercase;\">1. samm \u2013 suruge alla<\/p>\n<p style=\"font-size: 13.5px; color: #e2e8f0; margin: 0; line-height: 1.65;\">Korea patsient v\u00f5i apteeker surub CRC korki allapoole, surudes korgi \u00e4\u00e4rise vedruhambad kokku HDPE kaela\u00e4\u00e4rise kohal. Haakumis\u00e4\u00e4rise v\u00e4lisl\u00e4bim\u00f5\u00f5t m\u00e4\u00e4rab interferentsij\u00f5u: kui \u00e4\u00e4re v\u00e4lisl\u00e4bim\u00f5\u00f5t on liiga lai, \u00fcletab vajalik allasurumisj\u00f5ud Korea eaka patsiendi v\u00f5imekust (t\u00e4iskasvanute ligip\u00e4\u00e4setavuse puudumine). Kui \u00e4\u00e4re v\u00e4lisl\u00e4bim\u00f5\u00f5t on liiga kitsas, ei saa hammasratta hambad piisavalt kokku suruda ja CRC funktsioon kaob.<\/p>\n<\/div>\n<div style=\"padding: 16px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 10px; font-weight: bold; color: #f59e0b; margin: 0 0 10px; letter-spacing: 1px; text-transform: uppercase;\">2. samm \u2013 keerake vajutamise ajal<\/p>\n<p style=\"font-size: 13.5px; color: #e2e8f0; margin: 0; line-height: 1.65;\">Allapoole suunatud survet s\u00e4ilitades p\u00f6\u00f6ratakse korki (tavaliselt 30\u201345\u00b0), et joondada hammasratta hambad pudeli kaela keerme haakimiskoha algusega. Keerme v\u00e4lisl\u00e4bim\u00f5\u00f5t \u00b10,05 mm IBM-tolerants tagab, et keerme haakimiskoha algus j\u00e4\u00e4b kavandatud haakimispunktist 1\u20132\u00b0 piiresse, hoides \u00e4ra keerme ristl\u00f5ike kinnikiilumise, mis suurendaks keeramisj\u00f5udu \u00fcle spetsifikatsiooni ja ei l\u00e4biks t\u00e4iskasvanute ligip\u00e4\u00e4setavuse testi.<\/p>\n<\/div>\n<div style=\"padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; color: #f59e0b; margin: 0 0 10px; letter-spacing: 1px; text-transform: uppercase;\">3. samm \u2013 vabastamine ja kontrollimine<\/p>\n<p style=\"font-size: 13.5px; color: #e2e8f0; margin: 0; line-height: 1.65;\">Kork vabastatud \u2013 vedruhammas lukustab kinnitusr\u00f5nga uuesti, lukustades korgi avatud asendisse (laps ei saa seda uuesti sulgeda) v\u00f5i keermega suletud asendisse (toode on suletud). IBM-i kaelageomeetria tagab \u00fchtlase haardes\u00fcgavuse k\u00f5igis tootmis\u00f5\u00f5nsustes: haarde k\u00f5rgus \u00b10,05 mm, haarde profiili raadius \u00b10,03 mm \u2013 m\u00f5lemad on toodetud survevaluvormi kaelavahet\u00fckiga ja kontrollitud Korea Ever-Poweri tarneeelses tootmiskatses.<\/p>\n<\/div>\n<\/div>\n<div style=\"padding: 12px 20px; border-top: 1px solid #1e3a5f; background: #0a1628; display: grid; grid-template-columns: repeat(auto-fit,minmax(150px,1fr)); gap: 12px;\">\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">IBM OD HELM<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #34d399; margin: 0;\">\u00b10,05 mm<\/p>\n<\/div>\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">ISO 8317 AKEN<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #34d399; margin: 0;\">\u00b10,06 mm<\/p>\n<\/div>\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">EBM-i TOLERANTSUS<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #f87171; margin: 0;\">\u00b10,15\u20130,25 mm<\/p>\n<\/div>\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">T\u00d6\u00d6TLEMISE MARGINAAL<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #34d399; margin: 0;\">+0,01 mm IBM<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">IBM toodab CRC haarder\u00f5nga t\u00e4ielikult survevaluvormi kaela siset\u00fcki sees \u2013 see on t\u00e4ppist\u00f6\u00f6deldud teraskomponent, mis m\u00e4\u00e4rab \u00fche sissepritsek\u00e4iguga samaaegselt r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du, r\u00f5nga k\u00f5rguse, r\u00f5nga profiili raadiuse ja r\u00f5nga aksiaalse asendi. Kaela siset\u00fckk on valmistatud S136 roostevabast terasest (HRC 50\u201352) CNC-treimise tolerantsiga \u00b10,01 mm k\u00f5igil r\u00f5nga geomeetria m\u00f5\u00f5tmetel, mis annab valmis IBM-i konteineri r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5duks \u00b10,05 mm k\u00f5igis tootmis\u00f5\u00f5nsustes p\u00e4rast HDPE kahanemise kompensatsiooni arvestamist (0,8\u20131,2% rakendatakse vormi r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5dule kaela siset\u00fcki CNC-t\u00f6\u00f6tlemise ajal). Korea Ever-Poweri farmaatsiat\u00f6\u00f6stuse IBM-i kaela siset\u00fcki disain kasutab HDPE kahanemise l\u00f5plike elementide simulatsiooni r\u00f5nga tsoonis \u2013 r\u00f5nga lokaalselt k\u00f5rgem seinaosa kahaneb erinevalt k\u00fclgnevast silindrilisest kaelast \u2013, et arvutada \u00f5ige vormi r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5t, mis annab HDPE IBM-i t\u00f6\u00f6tlemistemperatuuril ja jahutuskiirusel m\u00e4\u00e4ratud anuma r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S3 \u2550\u2550 --><\/p>\n<section id=\"s3\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 03<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">Korea KS M ISO 8317 lapsekindla efektiivsuse testimine<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"IBM CRC konteinerite tootmine \u2014 Korea Ever-Power ZQ seeria\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-operating-principle.webp\" alt=\"IBM-i 3-jaamaline CRC ravimimahutite tootmine \u2014 CRC haakeserva survevalu 1. jaamas, konteineri korpuse puhumisvormimine 2. jaamas, eemaldamine 3. jaamas \u2014 Korea Ever-Power ZQ80 12-\u00f5\u00f5nsusega 100 ml CRC ravimimahuti IBM toodab konteinereid Korea KS M ISO 8317 lapsekindla sulguri kvalifitseerimistestideks\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">IBM-i 3-jaamaline CRC ravimimahutite tootmine \u2013 \u00fchendusr\u00f5ngas vormitakse survevalu teel 1. jaamas ja hoitakse s\u00fcdamikvarda abil m\u00f5\u00f5tmetelt stabiilsena kogu 2. jaamas toimuva puhumisfaasi v\u00e4ltel. 3. jaamas eemaldatakse valmis CRC-konteiner, mille r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5t on \u00b10,05 mm spetsifikatsiooni piires, mis on valmis Korea KS M ISO 8317 eelkvalifitseerimiseks ja seej\u00e4rel ametlikuks ISO 8317 inimkatseteks.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Korea KS M ISO 8317 on Korea riiklik standard lapsekindlate pakendite kohta, mis on \u00fchtlustatud standardiga ISO 8317:2015. See m\u00e4\u00e4rab kindlaks inimpaneeli testi, milles osaleb 200 t\u00e4iskasvanut ja 200 last, et kinnitada, et lapsekindlate pakendite sulgemiss\u00fcsteem vastab samaaegselt nii lapsekindluse (lapse madal avamiskiirus) kui ka t\u00e4iskasvanute ligip\u00e4\u00e4setavuse (t\u00e4iskasvanu k\u00f5rge avamiskiirus) n\u00f5uetele. Katse tuleb l\u00e4bi viia tegelike t\u00e4idetud tootmismahutitega \u2013 mitte t\u00fchjade mahutite v\u00f5i laboriproovidega \u2013, sest t\u00e4itekaal, vedeliku viskoossus ja sulguri kinnitusmoment m\u00f5jutavad k\u00f5ik lapsekindlate pakendite toimimist testis.<\/p>\n<p><!-- ISO 8317 test requirements --><\/p>\n<div style=\"display: flex; flex-direction: column; gap: 0; border: 1px solid #1e3a5f; border-radius: 6px; overflow: hidden; margin: 0 0 22px;\">\n<div style=\"background: #0f1e35; display: grid; grid-template-columns: repeat(3,1fr); gap: 0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; color: #d97706; margin: 0; letter-spacing: 1.5px; text-transform: uppercase;\">KATSE PARAMEETR<\/p>\n<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; color: #f59e0b; margin: 0; letter-spacing: 1.5px; text-transform: uppercase;\">LASTE PANEELI (42\u201351 kuud)<\/p>\n<\/div>\n<div style=\"padding: 12px 18px;\">\n<p style=\"font-size: 9px; font-weight: 800; color: #f59e0b; margin: 0; letter-spacing: 1.5px; text-transform: uppercase;\">T\u00c4ISKASVANUTE PANEEL (50\u201370 aastat)<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #fff; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">Paneeli suurus<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 14px; text-align: center;\">200 last<\/div>\n<div style=\"padding: 12px 18px; font-size: 14px; text-align: center;\">200 t\u00e4iskasvanut (vanuses 50\u201370)<\/div>\n<\/div>\n<div style=\"background: #f8fafc; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">Ajapiirang<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 14px; text-align: center;\">10 minutit<\/div>\n<div style=\"padding: 12px 18px; font-size: 14px; text-align: center;\">5 minutit (sisaldab taassulgemistesti)<\/div>\n<\/div>\n<div style=\"background: #fff; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">L\u00e4bimiskriteerium<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 14px; text-align: center;\"><strong style=\"color: #059669;\">\u2264 20%<\/strong> lastest avatud<\/div>\n<div style=\"padding: 12px 18px; font-size: 14px; text-align: center;\"><strong style=\"color: #059669;\">\u2265 85%<\/strong> t\u00e4iskasvanutest avatud<\/div>\n<\/div>\n<div style=\"background: #f8fafc; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">IBM-i kaela v\u00e4lisl\u00e4bim\u00f5\u00f5du l\u00f6\u00f6k<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 13.5px; color: #374151;\">K\u00f5rge v\u00e4lisl\u00e4bim\u00f5\u00f5t \u2192 rohkem takistusi \u2192 raskem avada \u2192 lastekindel \u2713, kuid t\u00e4iskasvanutele ligip\u00e4\u00e4smatu \u2717<\/div>\n<div style=\"padding: 12px 18px; font-size: 13.5px; color: #374151;\">Madal helme v\u00e4lisl\u00e4bim\u00f5\u00f5t \u2192 v\u00e4hem sekkumist \u2192 t\u00e4iskasvanutele lihtne juurdep\u00e4\u00e4s \u2713, kuid ebapiisav lastekindlus \u2717<\/div>\n<\/div>\n<div style=\"background: #fffbeb; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #fde68a;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #fde68a; font-weight: bold; font-size: 14px; color: #92400e;\">IBM-i eelis<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #fde68a; font-size: 13.5px; color: #92400e; font-weight: 600;\">IBM-i \u00b10,05 mm l\u00e4bim\u00f5\u00f5duga v\u00e4lisl\u00e4bim\u00f5\u00f5t hoiab k\u00f5ik tootmismahutid tolerantsivahemikus \u00b10,06 mm, mis vastab samaaegselt M\u00d5LEMALE kriteeriumile \u2013 see ei lase kunagi lapsekindlalt puruneda (liiga lihtne) ega t\u00e4iskasvanutele ligip\u00e4\u00e4setavalt puruneda (liiga raske).<\/div>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Korea KFDA ravimimahuti tehniline toimik peab sisaldama iga CRC-mahuti kohta Korea KS M ISO 8317 katsesertifikaati \u2013 dokumenti, mille on v\u00e4ljastanud Korea KS-i akrediteeritud katselabor, mis viis l\u00e4bi inimpaneeli testi, kasutades CTF-is tuvastatud IBM-i masina ja vormikomplekti tootmismahuteid. Korea Ever-Power pakub selle testi jaoks spetsiaalselt tarneeelsest tootmiskatsest p\u00e4rit CRC IBM-mahutite n\u00e4idiseid, mis v\u00f5imaldab Korea ravimibr\u00e4ndil esitada ISO 8317 katseproovid ja mahuti CTF-i samaaegselt, maksimeerides t\u00f5en\u00e4osust, et ISO 8317 testi l\u00e4bimise tulemus ja t\u00e4idetud CTF on Korea KFDA GMP kvalifikatsiooni l\u00e4bivaatamiseks samal ajal saadaval.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S4 \u2550\u2550 --><\/p>\n<section id=\"s4\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 04<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">HDPE klass ja helmeste geomeetria CRC IBM konteineritele<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Korea CRC farmaatsiatoodete IBM-konteinerid n\u00f5uavad spetsiifilist HDPE-kvaliteediga omadust, mida mitte-CRC farmaatsiatoodete IBM-konteinerid ei vaja: kinnitustsoon peab vastu pidama plastsele deformatsioonile CRC allasurumisj\u00f5u all. Kui CRC korki alla surutakse, rakendab see HDPE haardekinnitusele umbes 20\u201350 N allapoole suunatud j\u00f5udu \u2013 kinnitus peab p\u00e4rast surumisj\u00f5u vabanemist tagasi oma algsele v\u00e4lisl\u00e4bim\u00f5\u00f5dule vetruma, et s\u00e4ilitada j\u00e4rgmisel avamiskatsel \u00fchtlane lastekindlus. Ebapiisava j\u00e4ikusega HDPE (liiga k\u00f5rge MI v\u00f5i liiga madal tihedus) deformeerub korduvate surumisj\u00f5udude all j\u00e4\u00e4davalt, laiendades kinnituse v\u00e4lisl\u00e4bim\u00f5\u00f5tu aja jooksul ja v\u00e4hendades lastekindlust toote s\u00e4ilivusaja jooksul allapoole Korea ISO 8317 n\u00f5udeid.<\/p>\n<p><!-- bead geometry specification --><\/p>\n<div style=\"background: #0f1e35; border-radius: 4px; padding: 22px 26px; margin: 0 0 22px; border-top: 3px solid #d97706;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 16px;\">CRC HAAKUMISE RANDI GEOMEETRIA \u00b7 IBM-I SURVEVALU KAELA SISALDUSE SPETSIFIKATSIOON<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,180px),1fr)); gap: 1px; background: #1e3a5f;\">\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Helmeste v\u00e4lisl\u00e4bim\u00f5\u00f5t<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">Nimiv\u00e4\u00e4rtus \u00b10,01 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">Vormi\u00f5\u00f5nsus (HDPE kokkut\u00f5mbumise korrektsiooniga)<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Helmeste k\u00f5rgus<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">0,8\u20131,5 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">Silindri kaela nimil\u00e4bim\u00f5\u00f5dust k\u00f5rgemal \u2013 Korea CRC korgi tarnija spetsiifiline<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Rantprofiili raadius<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">R 0,3\u20130,6 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">Sujuv sissejuhatus CRC hammasratta hammaste haardumiseks \u2013 terav raadius suurendab haardumism\u00fcra ja j\u00f5udu<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Helmeste aksiaalne asend<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u00b10,20 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">Kaela tihendi maapind \u2013 m\u00e4\u00e4rab CRC korgi suletud asendi aksiaalse asukoha<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><!-- HDPE grade specs --><\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,280px),1fr)); gap: 14px; margin: 0 0 22px;\">\n<div style=\"background: #fff; border: 1px solid #e2e8f0; border-top: 3px solid #d97706; border-radius: 4px; padding: 18px 20px;\">\n<p style=\"font-size: 10px; font-weight: 800; letter-spacing: 2px; text-transform: uppercase; color: #d97706; margin: 0 0 12px;\">Korea CRC IBM \u2014 soovitatav HDPE klass<\/p>\n<div style=\"display: grid; grid-template-columns: 1fr 1fr; gap: 8px; margin-bottom: 14px;\">\n<div style=\"background: #f8fafc; padding: 10px 12px; border-radius: 3px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; font-weight: bold; margin: 0 0 3px; letter-spacing: 1px;\">MI (190 \u00b0C\/2,16 kg)<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #d97706; margin: 0;\">0,5\u20130,8<\/p>\n<\/div>\n<div style=\"background: #f8fafc; padding: 10px 12px; border-radius: 3px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; font-weight: bold; margin: 0 0 3px; letter-spacing: 1px;\">Tihedus (g\/cm\u00b3)<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #d97706; margin: 0;\">0,955\u20130,965<\/p>\n<\/div>\n<\/div>\n<p style=\"font-size: 14px; color: #374151; margin: 0; line-height: 1.65;\">Suurem tihedus (0,955\u20130,965) ja madalam MI (0,5\u20130,8) kui tavalisel farmatseutilisel HDPE IBM-il \u2013 see annab j\u00e4igema randi, mis peab vastu roomedeformatsioonile korduvate CRC-surutusts\u00fcklite ajal kogu Korea 24-kuulise ravimi s\u00e4ilivusaja jooksul. Korea CRC-konteinerite puhul, mis peavad s\u00e4ilitama lastekindluse p\u00e4rast 30 surumists\u00fcklit (Korea HIRA vastavus CRC-ts\u00fckli test), on eelistatud tihedus \u2265 0,958.<\/p>\n<\/div>\n<div style=\"background: #fff; border: 1px solid #e2e8f0; border-top: 3px solid #1e3a5f; border-radius: 4px; padding: 18px 20px;\">\n<p style=\"font-size: 10px; font-weight: 800; letter-spacing: 2px; text-transform: uppercase; color: #1e3a5f; margin: 0 0 12px;\">Helmeste deformatsiooni riskifaktorid<\/p>\n<ul style=\"margin: 0; padding-left: 0; list-style: none; display: flex; flex-direction: column; gap: 8px;\">\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>HDPE MI \u00fcle 1,0:<\/strong> ebapiisav molekulmass helmeste roomamiskindluse tagamiseks \u2013 Korea CRC ravimifirma IBM ei tohiks seda v\u00e4ltida<\/li>\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>Tihedus alla 0,952:<\/strong> Madalam kristallisus v\u00e4hendab helme j\u00e4ikust; ISO 8317 ts\u00fcklitesti eba\u00f5nnestumise risk suureneb p\u00e4rast 15+ surumists\u00fcklit<\/li>\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>T\u00fcnni temperatuur d\u00fc\u00fcsi juures \u00fcle 222 \u00b0C:<\/strong> Termiline lagunemine v\u00e4hendab HDPE molekulmassi randitsoonis \u2014 v\u00e4hendab j\u00e4ikust ja roomekindlust v\u00f5rreldes nominaalsete omadustega<\/li>\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>Ebapiisav kinnitusr\u00f5hk randiv\u00e4ravas:<\/strong> Alat\u00fchjalt t\u00e4idetud helmev\u00f6\u00f6ndis on mikrot\u00fchimikud, mis v\u00e4hendavad lokaalset tihedust \u2013 protsessi juhtimise indikaatorina m\u00f5\u00f5detakse helmev\u00f6\u00f6ndi k\u00f5vadust (Shore D) spetsifikatsiooni suhtes<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- \u2550\u2550 S5 \u2550\u2550 --><\/p>\n<section id=\"s5\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 05<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">IBM-i t\u00f6\u00f6tlemisparameetrid CRC-konteinerite jaoks<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">CRC farmaatsiatoodete IBM-i t\u00f6\u00f6tlemine Korea Ever-Power ZQ seeria masinatel n\u00f5uab kahe parameetri kohandamist v\u00f5rreldes farmaatsiatoodete mitte-CRC IBM-iga: k\u00f5rgem hoidmisr\u00f5hk (haarder\u00f5nga t\u00e4ielikuks t\u00e4itmiseks ja m\u00f5\u00f5tmete stabiilsuse tagamiseks) ja kaelatsooni tihedam jahutamine (et minimeerida kaelar\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du nihet p\u00e4rast v\u00e4ljutamist j\u00e4\u00e4ksoojuse t\u00f5ttu kaelar\u00f5nga tsoonis). K\u00f5ik muud parameetrid vastavad farmaatsiatoodete HDPE IBM-i standardsetele suunistele.<\/p>\n<div style=\"overflow-x: auto; margin: 0 0 22px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px; min-width: 540px;\">\n<thead>\n<tr style=\"background: #0f1e35;\">\n<th style=\"color: #f59e0b; padding: 11px 12px; text-align: left; font-weight: bold; border-right: 1px solid #1e3a5f;\">PARAMEETR<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">Standard Pharma IBM<\/th>\n<th style=\"color: #f59e0b; padding: 11px 10px; text-align: center; font-weight: bold;\">CRC PHARMA IBM \u2014 KOHANDAMINE<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">Hoidke r\u00f5hku<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">50\u201365% piigist<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">65\u201375% tipust \u2014 helmeala tsoon on t\u00e4is pakkimist<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">Hoidmisaeg<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">0,4\u20130,8 sekundit<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">0,6\u20131,0 s \u2013 pikendatud, et tagada randiava tihend<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">Kaelapiirkonna vormi temperatuur<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">14\u201318 \u00b0C<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">12\u201316 \u00b0C \u2013 tihedam jahutus helmeste tsoonis OD kiiremaks fikseerimiseks<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">M\u00f5\u00f5tmistsooni t\u00fcnn<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">200\u2013215 \u00b0C<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center;\">200\u2013215 \u00b0C (muutumatu)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-right: 1px solid #e2e8f0; font-weight: 600;\">Helmeste OD m\u00f5\u00f5tmise sagedus<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center;\">30 \u00f5\u00f5nsuse kohta partii alguses<\/td>\n<td style=\"padding: 9px 10px; text-align: center; font-weight: bold; color: #d97706;\">30 \u00f5\u00f5nsuse kohta + partii keskmine kontroll iga 2 tunni j\u00e4rel<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div style=\"background: #fff; border: 1px solid #e2e8f0; border-left: 4px solid #dc2626; padding: 14px 20px; border-radius: 0 4px 4px 0;\">\n<p style=\"font-size: 13.5px; color: #374151; margin: 0; line-height: 1.7;\"><strong style=\"color: #dc2626;\">\u26a0 R\u00c4\u00c4GI OD P\u00c4RAST V\u00c4LJASTAMIST TRIIV:<\/strong> CRC haardumisriba v\u00e4lisl\u00e4bim\u00f5\u00f5t, m\u00f5\u00f5detuna kohe eemaldamise ajal (jaam 3), on tavaliselt 0,02\u20130,04 mm suurem kui 30 minutit p\u00e4rast v\u00e4ljutamist m\u00f5\u00f5detud riba v\u00e4lisl\u00e4bim\u00f5\u00f5t \u2013 kuna riba tsoonis v\u00e4ljutamise ajal tekkiv j\u00e4\u00e4ksoojus v\u00f5imaldab HDPE kristalliseerumisest tingitud kokkut\u00f5mbumise j\u00e4tkumist, mis kitsendab riba v\u00e4lisl\u00e4bim\u00f5\u00f5tu veidi. Korea FDA kvalifitseerimiseks tuleb riba v\u00e4lisl\u00e4bim\u00f5\u00f5t v\u00f5tta p\u00e4rast seda, kui konteinerid on stabiliseerunud temperatuuril 23 \u00b0C \u00b1 2 \u00b0C v\u00e4hemalt 30 minutit p\u00e4rast v\u00e4ljutamist. R\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du proovide v\u00f5tmine kohe masina v\u00e4ljundkonveierilt ei ole Korea FDA jaoks kehtiv kvalifitseerimism\u00f5\u00f5t \u2013 see hindab s\u00fcstemaatiliselt \u00fcle stabiliseeritud tootmise v\u00e4lisl\u00e4bim\u00f5\u00f5tu.<\/p>\n<\/div>\n<\/section>\n<p><!-- \u2550\u2550 S6 \u2550\u2550 --><\/p>\n<section id=\"s6\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 06<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">CRC konteineri formaadi ja kaela viimistluse valik<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"Korea CRC farmaatsiatoodete IBM-i konteinerite formaatide valik \u2014 Korea EverPower\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Typles-0f-Bottle-1.webp\" alt=\"Korea CRC ravimite IBM-i konteinerite formaatide valik \u2014 60 ml l\u00fckand-keeratava CRC laste siirupi 28\/400 kaelaga ava, 100 ml l\u00fckand-keeratava CRC ravimipudel 33\/400 kaelaga ava, 150 ml CRC retseptiravimi vedelik 33\/400 \u2014 Korea Ever-Power ZQ80 CRC ravimite IBM-i konteinerid Korea KFDA KS M ISO 8317 kvalifikatsiooniga.\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">Korea CRC ravimite IBM-i konteinerite formaatide valik \u2013 alates 60 ml laste CRC siirupist (28\/400 l\u00fckand-keeratav, Korea HIRA prioriteetne vorm) kuni 100 ml retseptiravimite CRC-ni (33\/400, standardne t\u00e4iskasvanutele m\u00f5eldud Korea CRC formaat) ja 150 ml Korea mitmeannuselise retseptivedelikuni CRC-ga. K\u00f5ik formaadid on toodetud Korea Ever-Power ZQ seeria IBM-i masinatega, mille kinnitusr\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5t on tarnimiseelsel tootmiskatsel Korea CRC korgi tarnija kinnitusjoonise suhtes kontrollitud.<\/figcaption><\/figure>\n<div style=\"overflow-x: auto; margin: 0 0 22px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px; min-width: 600px;\">\n<thead>\n<tr style=\"background: #0f1e35;\">\n<th style=\"color: #f59e0b; padding: 11px 12px; text-align: left; font-weight: bold; border-right: 1px solid #1e3a5f;\">K\u00d6IDE<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">KAELA VIIMISTLUS<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">CRC T\u00dc\u00dcP<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">ZQ80 \u00f5\u00f5nsused<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: left; font-weight: bold;\">Korea taotlus<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold;\">30 ml<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">24\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">L\u00fckka ja keera<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">16\u201318<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0;\">Korea laste valuvaigisti, Korea vedel antibiootikum \u00fcksikdoosina<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold; color: #d97706;\">60 ml \u2605<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">28\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">L\u00fckka ja keera<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">14<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; font-weight: 600; color: #0f1e35;\">Korea laste siirup CRC (k\u00f5ige levinum Korea CRC formaat)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold;\">100 ml<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">33\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">L\u00fckka ja keera<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">10\u201312<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0;\">Korea retseptiravim suukaudne antibiootikum, Korea t\u00e4iskasvanutele m\u00f5eldud valuvaigistav vedelik<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold;\">150 ml<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">33\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">L\u00fckka ja keera<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">8<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0;\">Korea retseptiravim mitmeannuseline vedelik, Korea antatsiidsuspensioon CRC<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-right: 1px solid #e2e8f0; font-weight: bold;\">100\u2013150 ml<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">33\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center;\">Pigista ja keera<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">8\u201310<\/td>\n<td style=\"padding: 9px 10px;\">Korea artriidiga eaka patsiendi CRC (madalam allasurumisj\u00f5ud kui l\u00fckkamise ja p\u00f6\u00f6ramise korral)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 12px; color: #64748b; margin: 4px 0 0;\">\u2605 60 ml 28\/400 l\u00fckatava ja keeratava avaga CRC on Korea farmaatsiaettev\u00f5tte IBM-i etalon-CRC-formaat \u2013 Korea laste antibiootikumiretseptide suurima mahuga CRC-konteiner. Korea IBM-i tootjad kvalifitseerivad selle formaadi tavaliselt k\u00f5igepealt ja kasutavad seda mitmeformaadilise CRC tootmise planeerimise v\u00f5rdlusformaadina.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S7 \u2550\u2550 --><\/p>\n<section id=\"s7\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 07<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">CRC + induktsioontihendi kombineeritud formaat<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">CRC + induktsioontihendi kombineeritud formaat \u2013 CRC-kattekork, mis asetatakse induktsioontihendiga anuma peale \u2013 on Korea farmaatsiatootmises IBM-i kaelat\u00e4psusn\u00f5ude k\u00f5ige rangem. Korea HIRA mandaat lastele m\u00f5eldud vedelate retseptiravimite jaoks n\u00f5uab \u00fcha enam nii CRC-d (lasteohutus) kui ka induktsioontihendit (avamise t\u00f5end, niiskust\u00f5ke) samal primaarmahutil samaaegselt. See kombineeritud spetsifikatsioon n\u00f5uab, et IBM toodaks \u00fchele kaelavahele samaaegselt kolm s\u00f5ltumatut t\u00e4ppiselementi.<\/p>\n<p><!-- three requirements panel --><\/p>\n<div style=\"display: flex; flex-direction: column; gap: 0; border: 1px solid #1e3a5f; border-radius: 6px; overflow: hidden; margin: 0 0 22px;\">\n<div style=\"background: #0f1e35; display: grid; grid-template-columns: repeat(3,1fr); gap: 0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f; display: flex; align-items: center; gap: 8px;\">\n<div style=\"background: #d97706; color: #fff; font-size: 9px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">N\u00d5UANNE 01<\/div>\n<p><span style=\"font-size: 11px; font-weight: bold; color: #f59e0b; letter-spacing: 0.5px; text-transform: uppercase;\">CRC p\u00e4rli v\u00e4lisl\u00e4bim\u00f5\u00f5t<\/span><\/p>\n<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f; display: flex; align-items: center; gap: 8px;\">\n<div style=\"background: #d97706; color: #fff; font-size: 9px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">N\u00d5UANNE 02<\/div>\n<p><span style=\"font-size: 11px; font-weight: bold; color: #f59e0b; letter-spacing: 0.5px; text-transform: uppercase;\">Maapinna tasasuse tihendamine<\/span><\/p>\n<\/div>\n<div style=\"padding: 12px 18px; display: flex; align-items: center; gap: 8px;\">\n<div style=\"background: #d97706; color: #fff; font-size: 9px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">N\u00d5UANNE 03<\/div>\n<p><span style=\"font-size: 11px; font-weight: bold; color: #f59e0b; letter-spacing: 0.5px; text-transform: uppercase;\">Keerme v\u00e4lisl\u00e4bim\u00f5\u00f5t<\/span><\/p>\n<\/div>\n<\/div>\n<div style=\"background: #fff; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 16px 18px; border-right: 1px solid #e2e8f0; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #d97706; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 13px; color: #374151; margin: 0; line-height: 1.6;\">CRC l\u00fckkamis-ja-keeramisfunktsioon \u2014 hammasratta haardumise takistus Korea standardi ISO 8317 aknas<\/p>\n<\/div>\n<div style=\"padding: 16px 18px; border-right: 1px solid #e2e8f0; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #d97706; margin: 0 0 4px;\">\u00b10,10 mm TIR<\/p>\n<p style=\"font-size: 13px; color: #374151; margin: 0; line-height: 1.6;\">Induktsioonfooliumi hermeetiline \u00fchendus \u2013 t\u00e4ielik perimeetri kontakt fooliumi ja HDPE tihenduspinna vahel k\u00f5igis 14 \u00f5\u00f5nsuses<\/p>\n<\/div>\n<div style=\"padding: 16px 18px; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #d97706; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 13px; color: #374151; margin: 0; line-height: 1.6;\">CRC keerme haakumine \u2014 Korea apteekri keermega eemaldatav korgi haakumine p\u00e4rast induktsioonplommi purunemist<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #fffbeb; padding: 12px 20px; border-top: 1px solid #fde68a; display: flex; align-items: center; gap: 10px;\">\n<div style=\"width: 6px; height: 6px; background: #d97706; border-radius: 50%; flex-shrink: 0;\"><\/div>\n<p style=\"font-size: 13px; color: #92400e; margin: 0; font-weight: 600; line-height: 1.5;\">IBM-i survevaluvormi kaela siset\u00fckk t\u00e4idab k\u00f5ik kolm n\u00f5uet samaaegselt \u2013 see on toodetud \u00fchest S136 roostevabast terasest siset\u00fckist, mille k\u00f5ik kolm geomeetrilist elementi on t\u00f6\u00f6deldud t\u00e4psusega \u00b10,01 mm. Teisest t\u00f6\u00f6tlemist pole vaja. EBM ei suuda \u00fchtegi kolmest n\u00f5udest t\u00e4ita ilma kaela teisese viimistluseta.<\/p>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Korea KFDA (King Food and Drug Administration) poolt heaks kiidetud IBM-i konteineri CRC + induktsioontihendi kombineeritud kvalifitseerimine n\u00f5uab kahte eraldi sulguri funktsioonikatset, mis on lisatud konteineri tehnilisele dokumentatsioonile: Korea KS M ISO 8317 CRC efektiivsuskatse (inimestest, 200 t\u00e4iskasvanut + 200 last) ja induktsioontihendi terviklikkusekatse (100% mullikatse r\u00f5hul 10 kPa, pluss koorimisj\u00f5ud \u2265 8 N\/15 mm laius). M\u00f5lemas katses tuleb kasutada sama IBM-i tootmispartii tootmismahuteid kvalifitseeritud masinal ja \u00f5\u00f5nsuste arvuga. Korea Ever-Poweri tarneeelne tootmiskatse toodab m\u00f5lema testi jaoks samaaegselt n\u00e4idismahuteid, pakkudes Korea ravimibr\u00e4ndile k\u00f5iki vajalikke testproove \u00fche tarneeelse tootmispartii raames.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S8 \u2550\u2550 --><\/p>\n<section id=\"s8\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">JAGU 08<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">ZQ seeria valik Korea CRC IBM toodangu jaoks<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"Korea Ever-Poweri t\u00f6\u00f6tuba \u2014 CRC Pharmaceutical IBM Manufacturing\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/ever-power-workshop-1.webp\" alt=\"Korea Ever-Poweri IBM-i masinate tootmist\u00f6\u00f6koda \u2014 ZQ-seeria CRC farmaatsiatoodete IBM-i masinate tarneeelne tootmiskatse koos haardumisr\u00f5nga m\u00f5\u00f5tmete aruande genereerimisega Korea KFDA farmaatsiapakendite tehnilise faili KS M ISO 8317 CRC kvalifikatsiooni jaoks\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">Korea Ever-Poweri tootmis\u00fcksus \u2013 CRC farmaatsiatoodete IBM-i tootmise eelkatsetus. Iga eelkatsetuses toodetud CRC-konteineri haarde v\u00e4lisl\u00e4bim\u00f5\u00f5t m\u00f5\u00f5detakse neljas nurgaasendis (0\u00b0, 90\u00b0, 180\u00b0, 270\u00b0), et kinnitada haarde v\u00e4lisl\u00e4bim\u00f5\u00f5du ringikujulisust \u2264 0,04 mm TIR \u2013 ringikujulisuse n\u00f5ue tagab CRC hammasratta \u00fchtlase haardumise k\u00f5igis p\u00f6\u00f6rlemisasendites Korea KS M ISO 8317 paneelikatse ajal.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Korea CRC farmaatsiatoodete IBM-i ZQ-seeria masinate valik j\u00e4rgib sama aastast mahuraamistikku nagu teisedki farmaatsiatoodete IBM-i formaadid. CRC-spetsiifiline kaalutlus on see, et sama mahuga CRC-konteinerid v\u00f5imaldavad tavaliselt ZQ mudeli kohta v\u00e4hem \u00f5\u00f5nsusi v\u00f5rreldes sama mahuga mitte-CRC-konteineritega \u2013 kuna CRC haardeotsa suurem kaela v\u00e4lisl\u00e4bim\u00f5\u00f5t (ranti v\u00e4lisl\u00e4bim\u00f5\u00f5t on tavaliselt 1,6\u20133,0 mm suurem kui nimikaela v\u00e4lisl\u00e4bim\u00f5\u00f5t) suurendab \u00f5\u00f5nsuse kohta sissepritse kinnitusvajadust ja plaadi jalaj\u00e4lge \u00f5\u00f5nsuse kohta.<\/p>\n<div style=\"background: #0f1e35; border-radius: 4px; overflow: hidden; border-top: 3px solid #d97706; margin: 0 0 22px;\">\n<div style=\"padding: 14px 20px; border-bottom: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0;\">ZQ VALIKU MAATRIKS \u00b7 CRC IBM @ 60 ml 28\/400 L\u00dcKKA JA KEERA (HDPE MI 0.6)<\/p>\n<\/div>\n<div style=\"overflow-x: auto;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px; min-width: 580px;\">\n<thead>\n<tr style=\"background: #1e3a5f;\">\n<th style=\"color: #f59e0b; padding: 10px 12px; text-align: left; font-weight: bold; border-right: 1px solid #0f1e35;\">ZQ MUDEL<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: center; font-weight: bold; border-right: 1px solid #0f1e35;\">CAV 60 ml CRC juures<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: center; font-weight: bold; border-right: 1px solid #0f1e35;\">PUDELIT\/TUNN<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: center; font-weight: bold; border-right: 1px solid #0f1e35;\">AASTANE \u00dcLEMINEK<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: left; font-weight: bold;\">Korea CRC ravimiprofiili<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #0f1e35;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; font-weight: bold; color: #94a3b8;\">EP-ZQ40<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #94a3b8;\">6\u20138<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #94a3b8;\">~4800\u20136400<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #94a3b8;\">~16,8\u201322,4 miljonit<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; font-size: 12px; color: #64748b;\">Korea farmaatsia idufirma, Korea kolorektaalse v\u00e4hi kliiniline uuring, Korea haruldane lastehaigus<\/td>\n<\/tr>\n<tr style=\"background: #122338;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; font-weight: bold; color: #e2e8f0;\">EP-ZQ60<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">10\u201312<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~8000\u20139600<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~28,0\u201333,6 miljonit<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; font-size: 12px; color: #64748b;\">Korea keskmise suurusega laste- ja Korea geneeriline kolorektaalse v\u00e4hi ravim<\/td>\n<\/tr>\n<tr style=\"background: #fff9ec; border: 1px solid #d97706;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; font-weight: bold; color: #d97706;\">EP-ZQ80 \u2605<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; text-align: center; font-weight: bold; color: #0f1e35;\">14<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; text-align: center; font-weight: bold; color: #0f1e35;\">~11,200<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; text-align: center; font-weight: bold; color: #0f1e35;\">~39,2 miljonit<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; font-size: 12px; font-weight: 600; color: #92400e;\">Korea riikliku kaubam\u00e4rgiga laste antibiootikum CRC OEM \u2013 v\u00f5rdlusplatvorm<\/td>\n<\/tr>\n<tr style=\"background: #122338;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; font-weight: bold; color: #e2e8f0;\">EP-ZQ110<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">18<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~14,400<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~50,4 miljonit<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; font-size: 12px; color: #64748b;\">Korea suur farmaatsiatoodete CRC lepinguline pakendaja, Korea peamine lastebr\u00e4nd<\/td>\n<\/tr>\n<tr style=\"background: #0f1e35;\">\n<td style=\"padding: 9px 12px; border-right: 1px solid #1e3a5f; font-weight: bold; color: #f59e0b;\">EP-ZQ135<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #1e3a5f; text-align: center; font-weight: bold; color: #f59e0b;\">22<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #1e3a5f; text-align: center; font-weight: bold; color: #f59e0b;\">~17,600<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #1e3a5f; text-align: center; font-weight: bold; color: #f59e0b;\">~61,6 miljonit<\/td>\n<td style=\"padding: 9px 10px; font-size: 12px; color: #64748b;\">Korea riiklik laste antibiootikumide tarneahel, Korea haiglate varustamine CRC-ga ulatuslikult<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">See <a style=\"color: #1e3a5f; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/et\/product\/ep-zq80-injection-blow-molding-machine-european-style\/\">EP-ZQ80<\/a> 14 \u00f5\u00f5nsusega 60 ml CRC on Korea farmaatsiaettev\u00f5tte CRC IBM-i etalon \u2013 h\u00f5lmab 39 miljonit CRC laste siirupi \u00fchikut aastas Korea kahevahetuselise aasta jooksul \u00fches masinas, mis on kvalifitseeritud Korea KFDA farmaatsia GMP-le. ZQ80 kahekordne h\u00fcdros\u00fcsteem (standardne, energias\u00e4\u00e4stlik 20\u201330%) v\u00e4hendab HVAC-koormust Korea farmaatsiatoodete puhasruumis CRC tootmisel ning masina nurgajaotuse mehhanism tagab, et randi v\u00e4lisl\u00e4bim\u00f5\u00f5du \u00f5\u00f5nsustevaheline standardh\u00e4lve (\u00b11,8% CV% 14 \u00f5\u00f5nsusega ZQ80-l) j\u00e4\u00e4b tootmisjaotuse 99,7. protsentiilil tunduvalt alla \u00b10,05 mm spetsifikatsiooni \u2013 seda kinnitavad Korea Ever-Poweri tarneeelsed randi v\u00e4lisl\u00e4bim\u00f5\u00f5du ringikujulisuse ja \u00f5\u00f5nsustevaheliste m\u00f5\u00f5tmete aruanded, mis esitatakse iga farmaatsiaettev\u00f5tte CRC IBM-i masina tarnega.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 FAQ \u2550\u2550 --><\/p>\n<section style=\"margin: 64px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 24px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #0f1e35; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">TEHNIKA KKK<\/p>\n<h2 id=\"faq\" style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #fff; margin: 0; line-height: 1.2;\">CRC Pharmaceutical IBM \u2014 tehnilised k\u00fcsimused<\/h2>\n<\/div>\n<\/div>\n<div style=\"display: flex; flex-direction: column; gap: 2px;\">\n<div style=\"border: 1px solid #e2e8f0; border-radius: 4px 4px 0 0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">K 01<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Miks on IBM-i ainus eluj\u00f5uline puhumisvormimisprotsess Korea farmaatsiatoodete CRC-mahutite jaoks?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">IBM on Korea farmaatsiatoodete CRC-mahutite jaoks ainus teostatav puhumisvormimisprotsess, kuna Korea KS M ISO 8317 CRC haardumisr\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du tolerantsi n\u00f5ue (\u00b10,06 mm) j\u00e4\u00e4b IBM-i loomuliku protsessi v\u00f5imekuse piiresse (\u00b10,05 mm), kuid \u00fcletab EBM-i saavutatavat tolerantsi (\u00b10,15\u20130,25 mm) parimal juhul 2,5\u20134 korda. See ei ole marginaalne erinevus, mida kaela sekundaarne t\u00f6\u00f6tlemine suudab \u00fcletada: EBM-i kaela h\u00f5\u00f5ritsemisoperatsioonidel on oma m\u00f5\u00f5tmete varieeruvus (tavaliselt \u00b10,08\u20130,12 mm h\u00f5\u00f5ritsemistolerants), mis v\u00f5rdub v\u00f5i \u00fcletab kogu \u00b10,06 mm ISO 8317 haardumisakna. Isegi kui \u00fcksikuid EBM-konteinereid t\u00f6\u00f6deldakse l\u00e4bim\u00f5\u00f5duga \u00b10,06 mm t\u00e4psusega hermeetiku nimil\u00e4bim\u00f5\u00f5dust, p\u00f5hjustab puurimisoperatsiooni ts\u00fcklitevaheline varieeruvus selle, et osa tootmispartiist j\u00e4\u00e4b tolerantsi m\u00f5lemas otsas aknast v\u00e4ljapoole \u2013 ja Korea KS M ISO 8317 inimpaneel testib k\u00f5iki 200 t\u00e4iskasvanut ja 200 last sama konteinerit\u00fc\u00fcbiga, seega igasugune s\u00fcstemaatiline v\u00e4lisl\u00e4bim\u00f5\u00f5du varieeruvus kogu tootmispartiis (mille EBM + puurimine toodab) tekitab osa konteineritest, mis kas ei ole lapsekindlad (liiga laiad) v\u00f5i ei ole t\u00e4iskasvanutele ligip\u00e4\u00e4setavad (liiga kitsad). IBM k\u00f5rvaldab selle probleemi struktuuriliselt: IBM-i survevaluvormi kaelaosa toodab k\u00f5ik \u00f5\u00f5nsused nimil\u00e4bim\u00f5\u00f5duga \u00b10,05 mm ilma teisese t\u00f6\u00f6tlemiseta, ts\u00fcklitevahelise puurimise varieeruvuseta ja ilma protsessiahelata, milles teisese toimingu t\u00f5ttu v\u00f5ivad tekkida m\u00f5\u00f5tmete k\u00f5rvalekalded. See struktuuriline eelis on p\u00f5hjus, miks Korea farmaatsiaalased regulatiivsed asutused aktsepteerivad IBM-i CRC-konteinereid ainult IBM-i masina ja vormi kvalifitseerimise m\u00f5\u00f5tmete dokumentatsiooni alusel, ilma teisese t\u00f6\u00f6tlemise kontrollimiseta \u2013 lihtsustus, mida EBM + puurimine ei suuda saavutada.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">K 02<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Mis p\u00f5hjustab Korea p\u00e4ritolu CRC ravimikonteineri mittel\u00e4bimise t\u00e4iskasvanute ligip\u00e4\u00e4setavuse testis?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">Korea CRC farmaatsiatoodete IBM-i konteinerite ligip\u00e4\u00e4setavuse probleemid t\u00e4iskasvanutel \u2013 kus enam kui 15% 200 t\u00e4iskasvanud katsealusest (vanuses 50\u201370) ei suuda konteinerit 5 minuti jooksul avada \u2013 on IBM-i konteineri poolelt p\u00e4rit kolmel p\u00f5hjusel. Esiteks, tihendi v\u00e4lisl\u00e4bim\u00f5\u00f5t \u00fcle spetsifikatsiooni \u00fclempiiri: tihendi v\u00e4lisl\u00e4bim\u00f5\u00f5t, mis on nominaalsest + 0,05 mm suurem, suurendab CRC korgi allasurumisj\u00f5udu \u00fcle eaka Korea t\u00e4iskasvanu k\u00e4e haarde- ja allasurumisv\u00f5ime \u2013 anum on t\u00e4iskasvanute ligip\u00e4\u00e4semiseks liiga lapsekindel. Diagnostika: m\u00f5\u00f5tke tihendi v\u00e4lisl\u00e4bim\u00f5\u00f5t k\u00f5igist \u00f5\u00f5nsustest, mille tihendi v\u00e4lisl\u00e4bim\u00f5\u00f5t on spetsifikatsiooni \u00fclempiiri l\u00e4hedal v\u00f5i sellest k\u00f5rgem. P\u00f5hip\u00f5hjus: survevaluvormi kaela siset\u00fcki tihendi v\u00e4lisl\u00e4bim\u00f5\u00f5t on nominaalsest k\u00f5rgem (n\u00f5uab siset\u00fcki uuesti m\u00f5\u00f5tmist ja v\u00f5imalikku uuesti t\u00f6\u00f6tlemist); v\u00f5i HDPE kokkut\u00f5mbumine alla oodatut (tekib siis, kui vormi temperatuur on madalam kui kvalifitseeritud baasjoon, p\u00f5hjustades v\u00e4hem kristalliseerumist ja seega v\u00e4hem kokkut\u00f5mbumist ning suuremat tihendi v\u00e4lisl\u00e4bim\u00f5\u00f5tu kui kahanemise kompenseerimise prognoositud v\u00e4\u00e4rtus \u2013 suurendage vormi kaelatsooni jahutamist etten\u00e4htud seadev\u00e4\u00e4rtuseni). Teiseks, liiga terav randiprofiili raadius: nurgeline randiprofiil (raadius &lt; 0,3 mm) tekitab CRC korgi haardej\u00f5us astmelise funktsiooni \u2013 vajalik j\u00f5ud suureneb j\u00e4rsult, kui korgi hammasratas randiga haakub, mitte ei suurene j\u00e4rk-j\u00e4rgult, mist\u00f5ttu haakumine tundub \u00e4kiline ja vastupidav. IBM-i randiprofiili raadius peaks olema R 0,3\u20130,6 mm, nagu on t\u00e4psustatud 4. osas. Kolmandaks, HDPE-st efektiivse randi v\u00e4lisl\u00e4bim\u00f5\u00f5du roomav suurenemine: kui HDPE IBM-konteinerit on enne ISO 8317 testimist hoitud k\u00f5rgel temperatuuril (pikaajaliselt \u00fcle 30 \u00b0C), v\u00f5ib rand eelnevalt paigaldatud CRC korgi p\u00fcsiva haardej\u00f5u all v\u00e4ljapoole roomata, laiendades randi v\u00e4lisl\u00e4bim\u00f5\u00f5tu efektiivselt nimiv\u00e4\u00e4rtusest k\u00f5rgemaks. Korea ravimibr\u00e4ndid peaksid t\u00e4psustama, et ISO 8317 testimiseks kasutatavaid IBM-konteinereid ei ole p\u00e4rast tootmist hoitud temperatuuril \u00fcle 25 \u00b0C, ning peaksid l\u00e4bi viima ISO 8317 testimise 90 p\u00e4eva jooksul p\u00e4rast IBM-i tootmist, et v\u00e4ltida termiliselt p\u00f5hjustatud randi v\u00e4lisl\u00e4bim\u00f5\u00f5du triivi testproovi populatsioonis.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">K 03<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Kas CRC haakeserva v\u00e4lisl\u00e4bim\u00f5\u00f5t tuleb Korea CRC korgi tarnija jooniselt eraldi m\u00e4\u00e4rata v\u00f5i j\u00e4rgib IBM-i vorm korgi tarnija nominaaldiagrammi?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">IBM-i konteineri haarde v\u00e4lisl\u00e4bim\u00f5\u00f5t tuleb m\u00e4\u00e4rata eraldi Korea CRC korgi tarnija haardejoonise nominaalv\u00e4\u00e4rtusest \u2013 see ei saa lihtsalt j\u00e4rgida korgi nominaalv\u00e4\u00e4rtust ilma haardes\u00fcsteemi projekteeritud pingutussobivust arvestamata. L\u00fckka-ja-keeratav CRC mehhanism toimib nii, et CRC korgi kinnitusmutter haakub pudelikaela randiga projekteeritud pingutussuhtega: korgi haarde l\u00e4bim\u00f5\u00f5t on tahtlikult v\u00e4iksem kui randi v\u00e4lisl\u00e4bim\u00f5\u00f5t projekteeritud pingutussuhte v\u00f5rra (tavaliselt 0,10\u20130,20 mm, mille on m\u00e4\u00e4ranud Korea CRC korgi tootja). Kui IBM-i konteineri randi v\u00e4lisl\u00e4bim\u00f5\u00f5t v\u00f5rdub CRC korgi haardemehhanismi nominaalv\u00e4\u00e4rtusega \u2013 ilma projekteeritud pingutuseta \u2013, libiseb hammasratas \u00fcle randi ilma kl\u00f5psumiseta, luues konteineri, mis l\u00e4bib t\u00e4iskasvanute ligip\u00e4\u00e4su (kergesti avatav), kuid ei ole lastekindlalt l\u00e4bitav (lapsed saavad selle ka lihtsalt avada). \u00d5ige IBM-i randi v\u00e4lisl\u00e4bim\u00f5\u00f5du spetsifikatsioon on: Korea CRC korgi tarnija haardemehhanismi nominaalv\u00e4\u00e4rtus + projekteeritud pingutus (CRC korgi tarnija vastaskomponendi jooniselt) = IBM-i konteineri randi v\u00e4lisl\u00e4bim\u00f5\u00f5t nominaalv\u00e4\u00e4rtusega, rakendades \u00b10,05 mm IBM-i tolerantsi. Korea Ever-Power n\u00f5uab Korea farmaatsiabr\u00e4ndilt Korea CRC korgi tarnija t\u00f6\u00f6v\u00f5tujoonise esitamist enne IBM-i kaela siset\u00fcki CNC-t\u00f6\u00f6tlemist \u2013 kaela siset\u00fckile t\u00f6\u00f6deldud randi v\u00e4lisl\u00e4bim\u00f5\u00f5du nimim\u00f5\u00f5t tuletatakse CRC korgi jooniselt, mitte IBM-i geneerilisest farmaatsiastandardist. Ilma selle korgi tarnija jooniseta ei saa IBM-i vormi kaela siset\u00fckki \u00f5igesti dimensioneerida ja ISO 8317 testi eba\u00f5nnestumine on t\u00f5en\u00e4oline esimesel esitamisel.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">K 04<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Kas sama ZQ masin saab k\u00e4itada nii CRC kui ka mitte-CRC farmaatsiatoodete IBM-i vorminguid?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">Jah \u2014 sama ZQ-seeria masin suudab k\u00e4itada CRC ja mitte-CRC farmaatsia IBM-formaate, kasutades erinevaid vormikomplekte, kusjuures iga vormikomplekti tootmisretsept on salvestatud ZQ juhtimiss\u00fcsteemi ja operaator saab selle vormivahetuse ajal uuesti meelde tuletada. ZQ80, mis k\u00e4itab 14-\u00f5\u00f5nsusega 60 ml CRC laste siirupi vormikomplekti (HDPE MI 0,6, hoider\u00f5hk 70%, kaelajahutus 13 \u00b0C), suudab p\u00e4rast vormivahetust ja retsepti tagasikutsumist k\u00e4itada ka 20-\u00f5\u00f5nsusega 10 ml oftalmoloogilise vormikomplekti (HDPE MI 0,4, hoider\u00f5hk 60%, kaelajahutus 15 \u00b0C) \u2014 masina riistvara ei muutu formaatide vahel. Korea KFDA farmaatsiapakendite kvalifikatsioon on aga konteinerispetsiifiline: 60 ml CRC vormikomplekt ja 10 ml oftalmoloogilise vormikomplekt vajavad kumbki oma eraldi pakendi tehnilisi dokumente koos oma \u00f5\u00f5nsuste kaupa m\u00f5\u00f5tude aruannetega \u2014 m\u00f5lemad on toodetud sama ZQ80 masina seerianumbriga, kuid erinevatest vormikomplektidest. Korea farmaatsiatoodete IBM-i tootjad peaksid masina kvalifitseerimisdokumentatsioonis identifitseerima m\u00f5lemad vormikomplektid \u2013 registreerides m\u00f5lema vormi seerianumbrid oma Korea GMP tootmise p\u00f5hifailis oleva \u00fche ZQ80 masina seerianumbri vastu \u2013, et toetada auditeerimisj\u00e4lge Korea MFDS GMP kontrollide jaoks mitmeformaadilise farmaatsiatoodete IBM-i tootmise puhul samal masinal.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">K 05<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Kuidas kontrollitakse IBM-i lepingulise r\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5tu p\u00e4rast Korea Ever-Poweri vormi tarnimist ja enne Korea KFDA kvalifitseerimise esitamist?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">IBM-i haakeservade v\u00e4lisl\u00e4bim\u00f5\u00f5du kontrollimine Korea KFDA CRC kvalifitseerimiseks kasutab spetsiifilist m\u00f5\u00f5tmisprotokolli, mis erineb standardsest farmaatsiatoodete kaela v\u00e4lisl\u00e4bim\u00f5\u00f5du m\u00f5\u00f5tmisest. Standardne farmaatsiatoodete kaela v\u00e4lisl\u00e4bim\u00f5\u00f5du m\u00f5\u00f5tmine kasutab kontaktdigitaalset nihikut v\u00f5i laseriga v\u00e4lisl\u00e4bim\u00f5\u00f5du m\u00f5\u00f5turit, mis m\u00f5\u00f5dab kaela suurimat l\u00e4bim\u00f5\u00f5tu \u00fches tasapinnas. CRC haakeservade v\u00e4lisl\u00e4bim\u00f5\u00f5du m\u00f5\u00f5tmine n\u00f5uab: (1) m\u00f5\u00f5tmist neljas nurgaasendis \u00fcmber randi \u00fcmberm\u00f5\u00f5du (0\u00b0, 90\u00b0, 180\u00b0, 270\u00b0) iga konteineri kohta \u2013 kinnitades randi ringikujulisust (\u00fcmaruse puudumine \u2264 0,04 mm TIR) ja randi nimil\u00e4bim\u00f5\u00f5tu; (2) m\u00f5\u00f5tmist randi maksimaalse l\u00e4bim\u00f5\u00f5du punktis (randi k\u00f5rgeim punkt kaelasilindri kohal) \u2013 kasutades astmelist kontaktandurit, mitte nihikut, sest nihiku l\u00f5uad, mis ulatuvad kogu kaela l\u00e4bim\u00f5\u00f5duni, m\u00f5\u00f5davad kaela v\u00e4lisl\u00e4bim\u00f5\u00f5du keskmist, mitte maksimaalset; (3) Statistiline anal\u00fc\u00fcs: 30 m\u00f5\u00f5tmist \u00f5\u00f5nsuse kohta (120 m\u00f5\u00f5tmistulemust \u00f5\u00f5nsuse kohta 4-nurkpositsiooni protokolli puhul) k\u00f5igis tootmis\u00f5\u00f5nsustes, kusjuures Cpk \u2265 1,33 kinnitus randi v\u00e4lisl\u00e4bim\u00f5\u00f5du kohta nimiv\u00e4\u00e4rtuse \u00b10,05 mm juures. Korea Ever-Power kasutab tarneeelse tootmiskatse ajal spetsiaalset randi v\u00e4lisl\u00e4bim\u00f5\u00f5du astmelist kontaktm\u00f5\u00f5tes\u00fcsteemi, mille andmed edastatakse otse \u00f5\u00f5nsuste kaupa randi v\u00e4lisl\u00e4bim\u00f5\u00f5du m\u00f5\u00f5tmete aruande vormingusse, mis on n\u00f5utav Korea farmaatsiapakendite tehnilise toimiku esitamiseks. See spetsiaalne m\u00f5\u00f5tes\u00fcsteem ei ole enamikus Korea IBM-i konteinerite tootmis\u00fcksustes saadaval \u2013 Korea Ever-Power pakub tarneeelset randi v\u00e4lisl\u00e4bim\u00f5\u00f5du aruannet just seet\u00f5ttu, et neid spetsiaalseid m\u00f5\u00f5tmisandmeid ei ole Korea kliendi tootmis\u00fcksuses tavaliselt v\u00f5imalik korrata ilma Korea Ever-Poweri m\u00f5\u00f5tevahendite toeta.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 0 0 4px 4px; overflow: hidden; margin-bottom: 64px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">K 06<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Mis juhtub Korea CRC ravimi IBM-i lastekindla pakendiga toote 24-kuulise s\u00e4ilivusaja jooksul?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">Korea CRC farmaatsiatoodete IBM-i konteineri lastekindlus muutub 24-kuulise s\u00e4ilivusaja jooksul Koreas kahe mehhanismi kaudu: HDPE haardumisr\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du triiv ja CRC korgi vedru hammasratta v\u00e4simus. IBM-i konteineri k\u00fcljel oleva haardumisr\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5du triiv: HDPE kristalliseerumine j\u00e4tkub Korea toatemperatuuril (jaem\u00fc\u00fcgiapteekides 15\u201325 \u00b0C, Korea majapidamistingimustes 10\u201330 \u00b0C) aeglaselt umbes 6\u201312 kuud p\u00e4rast tootmist \u2013 selle aja jooksul v\u00e4heneb haardumisr\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5t tavaliselt veidi (0,01\u20130,03 mm) kristallilise faasi tihenemise j\u00e4tkuva t\u00f5ttu. See v\u00e4lisl\u00e4bim\u00f5\u00f5du v\u00e4henemine suurendab veidi CRC haardumisr\u00f5nga interferentsi, muutes konteineri 6\u201312 kuu m\u00f6\u00f6dudes marginaalselt lastekindlamaks v\u00f5rreldes tootmisega \u2013 see on Korea FDA vastavuse seisukohast \u00fcldiselt konservatiivne muutus. 12 kuu m\u00f6\u00f6dudes on HDPE kristalliseerumine l\u00f5ppenud ja haardumisr\u00f5nga v\u00e4lisl\u00e4bim\u00f5\u00f5t on tavap\u00e4rastes Korea farmaatsiatoodete s\u00e4ilitustingimustes m\u00f5\u00f5tmetelt stabiilne \u00fclej\u00e4\u00e4nud 24-kuulise s\u00e4ilivusaja jooksul. CRC korgi vedruhamba v\u00e4simus (probleem on pigem korgi kui IBM-i konteineri poolel): CRC korgi pol\u00fcprop\u00fcleenist vedruhamba hambad kaotavad 24 kuu jooksul temperatuuril 20\u201325 \u00b0C Koreas s\u00e4ilitamisel ligikaudu 8\u201315% oma elastsusmoodulist \u2013 see v\u00e4hendab veidi survej\u00f5udu, mis on vajalik hammasratta randi kohale vajutamiseks, ja potentsiaalselt suurendab Korea t\u00e4iskasvanud katsealuste osakaalu, kes suutsid ISO 8317 kordustesti k\u00e4igus 24 kuu m\u00f6\u00f6dudes konteineri avada. Korea ravimibr\u00e4ndid, mis m\u00e4\u00e4ravad CRC konteineritele 24-kuulise s\u00e4ilivusaja Koreas, peaksid oma Korea CRC korgi tarnijaga kontrollima, et korgi vedruhamba v\u00e4simusandmed (elastsusmooduli s\u00e4ilivus 24 kuu m\u00f6\u00f6dudes Korea s\u00e4ilitustingimustes) toetavad j\u00e4tkuvat vastavust ISO 8317 t\u00e4iskasvanute ligip\u00e4\u00e4setavuse ja lastekindluse n\u00f5uetele kogu s\u00e4ilivusaja jooksul \u2013 IBM-i konteineri randi v\u00e4lisl\u00e4bim\u00f5\u00f5du stabiilsus ei ole piirav tegur; korgi materjali toimivus on.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- CTA --><\/p>\n<div style=\"margin: 0 0 72px; background: #0f1e35; border-radius: 4px; overflow: hidden; position: relative;\">\n<div style=\"height: 4px; background: linear-gradient(90deg,#d97706,#f59e0b,#d97706);\"><\/div>\n<div style=\"position: absolute; right: 0; top: 0; bottom: 0; width: 40%; background: linear-gradient(135deg,transparent 0%,rgba(30,58,95,0.5) 100%); pointer-events: none;\"><\/div>\n<div style=\"position: relative; padding: clamp(32px,5vw,52px) clamp(24px,4vw,48px); text-align: center;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 14px;\">CRC PHARMACEUTICAL IBM-I P\u00c4RING \u00b7 KOREA EVER-POWER<\/p>\n<h2 style=\"font-size: clamp(18px,3vw,28px); font-weight: 900; color: #fff; margin: 0 0 14px; letter-spacing: -0.5px;\">Kas plaanite Koreas CRC farmaatsiatoodete IBM-i konteinerite tootmist?<\/h2>\n<p style=\"font-size: 15px; color: #94a3b8; max-width: 520px; margin: 0 auto 28px; line-height: 1.65;\">Korea Ever-Power pakub CRC haakeserva v\u00e4lisl\u00e4bim\u00f5\u00f5du m\u00f5\u00f5tmete kvalifitseerimist eeltarnetava tootmisproovi p\u00f5hjal, Korea KS M ISO 8317 katsen\u00e4idise konteinereid, KFDA GMP dokumentatsioonipaketti ja ZQ-seeria masina valikut Korea CRC ravimikonteinerite IBM-i tootmiseks k\u00f5igil aastamahtudel.<\/p>\n<p><a style=\"display: inline-flex; align-items: center; gap: 8px; background: #d97706; color: #fff; padding: 14px 36px; border-radius: 3px; text-decoration: none; font-weight: 800; font-size: 14px; letter-spacing: 0.5px; text-transform: uppercase;\" href=\"https:\/\/isbm-blow-molding.com\/et\/contact-us\/\">Taotle CRC IBM-i konsultatsiooni <span style=\"font-size: 16px;\">\u2192<\/span><\/a><\/p>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>CRC PHARMACEUTICAL IBM \u00b7 KS M ISO 8317 \u00b7 KOREAN KFDA \u00b7 KOREA EVER-POWER CRC Pharmaceutical IBM: Child-Resistant Container Guide Korean child-resistant closure (CRC) pharmaceutical containers are the application where IBM&#8217;s \u00b10.05 mm neck OD precision is not merely an advantage over EBM \u2014 it is the prerequisite for Korean KS M ISO 8317 compliance. [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-1084","post","type-post","status-publish","format-standard","hentry","category-technical-deep-dive"],"_links":{"self":[{"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/posts\/1084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/comments?post=1084"}],"version-history":[{"count":2,"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/posts\/1084\/revisions"}],"predecessor-version":[{"id":1088,"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/posts\/1084\/revisions\/1088"}],"wp:attachment":[{"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/media?parent=1084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/categories?post=1084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/et\/wp-json\/wp\/v2\/tags?post=1084"}],"curies":[{"name":"t\u00f6\u00f6leht","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}